Metro Healthcare Berhad (KLSE:METRO)
Malaysia · Delayed Price · Currency is MYR 0.2200
0.00 (0.00%)
At close: Jun 9, 2026
Metro Healthcare Berhad Cash Flow Statement
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 6.56 | 5.86 | 4.56 | 6.25 | 5.02 | 9.44 |
Depreciation & Amortization | 5.63 | 5.64 | 5.43 | 5.01 | 6.78 | 5.57 |
Loss (Gain) From Sale of Assets | -0.02 | -0.02 | - | -0.03 | -0.22 | -0.02 |
Asset Writedown & Restructuring Costs | 0.11 | 0.11 | 0.02 | 0.25 | 0.06 | 0.42 |
Loss (Gain) From Sale of Investments | 0.27 | 0.49 | 0.12 | 0.07 | -0.08 | -0.58 |
Stock-Based Compensation | - | - | - | 0.2 | -0.04 | 0.43 |
Provision & Write-off of Bad Debts | - | - | - | - | 0 | 0.05 |
Other Operating Activities | -0.85 | -0.53 | 0.3 | 0.11 | -3.89 | -2.65 |
Change in Accounts Receivable | 0.99 | -1.16 | 0.19 | 0.24 | 0.7 | -0.7 |
Change in Inventory | -0.46 | -0.45 | -0.49 | -0.31 | -0.15 | -0.49 |
Change in Accounts Payable | -0.79 | -0.87 | -0.14 | -0.86 | 1.06 | 0.64 |
Operating Cash Flow | 11.44 | 9.07 | 9.99 | 10.93 | 9.25 | 12.1 |
Operating Cash Flow Growth | 66.22% | -9.25% | -8.60% | 18.21% | -23.58% | 66.60% |
Capital Expenditures | -3.38 | -1.48 | -4.42 | -3.55 | -4.58 | -4.9 |
Sale of Property, Plant & Equipment | 0.02 | 0.02 | - | 0.11 | 0.25 | 0.02 |
Cash Acquisitions | -0.27 | - | - | - | - | - |
Investment in Securities | 0.38 | 0.38 | -0.81 | - | -0.41 | 1.22 |
Other Investing Activities | 0.14 | 0.13 | 0.25 | 0.1 | 0.1 | 0.07 |
Investing Cash Flow | -3.1 | -0.94 | -4.98 | -3.34 | -4.64 | -3.58 |
Long-Term Debt Repaid | - | -2.55 | -2.45 | -2.4 | -1.52 | -4.07 |
Total Debt Repaid | -2.53 | -2.55 | -2.45 | -2.4 | -1.52 | -4.07 |
Net Debt Issued (Repaid) | -2.53 | -2.55 | -2.45 | -2.4 | -1.52 | -4.07 |
Issuance of Common Stock | - | - | 38.12 | - | - | 3.12 |
Common Dividends Paid | -6.36 | -6.36 | -4.44 | -4.32 | -4.07 | -1.34 |
Financing Cash Flow | -8.89 | -8.91 | 31.23 | -6.72 | -5.59 | -2.28 |
Net Cash Flow | -0.55 | -0.78 | 36.25 | 0.87 | -0.97 | 6.24 |
Free Cash Flow | 8.06 | 7.59 | 5.58 | 7.38 | 4.67 | 7.21 |
Free Cash Flow Growth | 120.70% | 36.14% | -24.47% | 58.02% | -35.16% | 164.44% |
Free Cash Flow Margin | 15.96% | 15.06% | 11.46% | 16.52% | 11.60% | 17.05% |
Free Cash Flow Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Cash Interest Paid | - | - | - | - | - | 0.03 |
Cash Income Tax Paid | 2.66 | 3.19 | 2.77 | 2.65 | 3.33 | 3.01 |
Levered Free Cash Flow | 6.77 | 6.22 | 4.65 | 5.85 | 6.54 | 8.08 |
Unlevered Free Cash Flow | 7.16 | 6.61 | 5.08 | 6.31 | 6.79 | 8.31 |
Change in Working Capital | -0.26 | -2.48 | -0.44 | -0.93 | 1.61 | -0.54 |